Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy

Celette Sugg Skinner, Susan M. Rawl, Barry K. Moser, Adam H. Buchanan, Linda L. Scott, Victoria L. Champion, Joellen M. Schildkraut, Giovanni Parmigiani, Shelly Clark, David F. Lobach, Lori A. Bastian

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Abstract

The Cancer Risk Intake System (CRIS), a computerized program that "matches" objective cancer risks to appropriate risk management recommendations, was designed to facilitate patient-clinician discussion. We evaluated CRIS in primary care settings via a single-group, self-report, pretest-posttest design. Participants completed baseline telephone surveys, used CRIS during clinic visits, and completed follow-up surveys 1 to 2 months postvisit. Compared with proportions reporting having had discussions at baseline, significantly greater proportions of participants reported having discussed tamoxifen, genetic counseling, and colonoscopy, as appropriate, after using CRIS. Most (79%) reported CRIS had "caused" their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings.

Original languageEnglish (US)
Pages (from-to)360-365
Number of pages6
JournalJournal of general internal medicine
Volume20
Issue number4
DOIs
StatePublished - Apr 2005

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Impact of the cancer risk intake system on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy'. Together they form a unique fingerprint.

Cite this